PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0026FA029Inhaled NITRIC OXIDE — Ino Therapeutics LLC

Ino Therapeutics LLC holds $2.5M across 84 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards under parent V797D60737. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrc0 West

Awarding office

Ino Therapeutics LLC

Recipient

Dec 31, 2026

PoP end

$158K

Obligated

$158K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ino Therapeutics LLC — $90

Contract facts

Federal

Contract numberW81K0026FA029

Also listed asV797D60737-W81K0026FA029

AgencyW40m Mrc0 West

Awarding officeW40m Mrc0 West

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentIno Therapeutics LLC

CAGE1PVS3

UEIXXQHL619FUN6

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVV797D60737

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJan 1, 2026

PoP end (current)Dec 31, 2026

Obligated$158K

Current value$158K

Potential value$158K

INHALED NITRIC OXIDE is a federal award for W40m Mrc0 West held by Ino Therapeutics LLC. Estimated value $158K ($158K obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: SAN ANTONIO TX.

Recompete timing

Public

● Expiring in 132 days

Current PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ino Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($2.5M) · all agencies

Department of Defense (DOD)$1.9M · 76%Department of Veterans Affairs (VA)$654K · 26%

Open full company profile →

Related awards

Same parent · incumbent

75N90024F00080

INO THERAPEUTICS INC:1107599 [26-001138]

$115K

Feb 28, 2027

36C25022F0432

EXERCISING OY1 THE HOURLY RATE IS CHANGING FROM $49.58 PER HOUR TO $38.91 PER HOUR BEGINNI…

$293K

Apr 26, 2027

36C24723F0049

INO THERAPUETIC

$207K

Sep 30, 2027

36C24223N0086

INOMAX NITRIC OXIDE GAS CYLINDER DELIVERY SERVICE

$149K

Sep 30, 2027

36C24623C0012

NITRIC OXIDE GAS

$410K

Dec 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0026FA029?

W81K0026FA029 (Inhaled NITRIC OXIDE) is a W40m Mrc0 West award with a potential value of $158K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W81K0026FA029?

W40m Mrc0 West awarded W81K0026FA029 to Ino Therapeutics LLC (potential $158K).

Who is the incumbent on W81K0026FA029?

Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Ino Therapeutics LLC’s W81K0026FA029 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Dec 17, 2025